At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies that advance the existing standard of care, and enrich the lives and treatment alternatives for patients worldwide.
Solutions for Healthcare Providers
iStent inject® W
iStent inject® W represents the next generation of Glaukos trabecular micro-bypass technology, which has been proven safe and effective in hundreds of thousands of eyes worldwide. It creates two bypass pathways through the trabecular meshwork, resulting in multi-directional flow through Schlemm’s canal, and is advancing the standard of care for glaucoma patients.
Learn how iStent inject® W, when used in conjunction with cataract surgery, is transforming the treatment of glaucoma.View Info
Market Access Support
As a service to our customers, Glaukos provides a reimbursement & billing guide with sample claim forms. Here you’ll find information including coding options, coverage highlights, as well as information for private payers.
Contact Us Today to Integrate iStent inject® W Into Your Practice
Complete the form to get started with offering iStent inject® W to your patients. You’ll also receive five posters presented at ARVO 2021 highlighting the efficacy and safety of the iStent platform as compared to other procedures.